Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Consolidated Net Income: 2016-2025

Historic Consolidated Net Income for Anaptysbio (ANAB) over the last 10 years, with Sep 2025 value amounting to $15.1 million.

  • Anaptysbio's Consolidated Net Income rose 146.00% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year increase of 48.91%. This contributed to the annual value of -$145.2 million for FY2024, which is 11.24% up from last year.
  • Anaptysbio's Consolidated Net Income amounted to $15.1 million in Q3 2025, which was up 139.12% from -$38.6 million recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Consolidated Net Income ranged from a high of $15.1 million in Q3 2025 and a low of -$46.7 million during Q2 2024.
  • For the 3-year period, Anaptysbio's Consolidated Net Income averaged around -$33.8 million, with its median value being -$39.3 million (2025).
  • As far as peak fluctuations go, Anaptysbio's Consolidated Net Income plummeted by 6,121.91% in 2022, and later spiked by 146.00% in 2025.
  • Over the past 5 years, Anaptysbio's Consolidated Net Income (Quarterly) stood at -$31.1 million in 2021, then climbed by 28.80% to -$22.1 million in 2022, then slumped by 90.71% to -$42.2 million in 2023, then spiked by 48.39% to -$21.8 million in 2024, then soared by 146.00% to $15.1 million in 2025.
  • Its last three reported values are $15.1 million in Q3 2025, -$38.6 million for Q2 2025, and -$39.3 million during Q1 2025.